Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Here’s Why

Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped up before the market opened on Wednesday . The stock had previously closed at $15.00, but opened at $16.11. Ono Pharmaceutical shares last traded at $16.11, with a volume of 300 shares traded.

Analyst Ratings Changes

Separately, Zacks Research lowered shares of Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research note on Friday, September 4th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Ono Pharmaceutical Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 3.28 and a quick ratio of 2.86. The stock’s 50-day simple moving average is $14.89 and its 200 day simple moving average is $14.60. The stock has a market capitalization of $7.57 billion, a P/E ratio of 15.34 and a beta of 0.33.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd. is a Japanese research-driven pharmaceutical company headquartered in Osaka. The company discovers, develops, manufactures and markets prescription medicines, with a focus on oncology, immunology, neurology and other specialty-care areas. Its activities include both internally developed products and collaborations with pharmaceutical and biotechnology companies worldwide.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used to treat multiple types of cancer.